Literature DB >> 15782625

Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western Blot methods for the diagnosis of culture-confirmed early Lyme borreliosis in Italy.

Antonella Marangoni1, Monica Sparacino, Valeria Mondardini, Francesca Cavrini, Elisa Storni, Manuela Donati, Roberto Cevenini, Vittorio Sambri.   

Abstract

This study investigated the onset and development of the immune response to Borrelia burgdorferi infection in 30 Italian patients with culture-confirmed Lyme Borreliosis in the stage of erythema migrans (EM). All patients received antimicrobial treatment when entering the study and were prospectively evaluated monthly for up to 30 days after enrolment. A total of 60 serially collected serum samples were tested by using two different commercial enzyme-linked immunosorbent assays (ELISAs): Anti-Borrelia plus VlsE ELISA, Euroimmun, and the synthetic peptide-based ELISA, Quick ELISA C6, Immunetics. Sixty-five potentially cross-reacting sera were also tested. Anti-Borrelia plus VlsE ELISA IgG was far more sensitive than Quick ELISA C6 (56.6% and 33.3%, respectively). Moreover, considering that 17 additional sera from the first bleeding group of Lyme disease patients were IgM positive when tested by Anti-Borrelia plus VlsE IgM, the sensitivity of Anti-Borrelia plus VlsE as a whole system rose to 85.0%. Nevertheless, due to the specificity values of Anti-Borrelia plus VlsE ELISA identified in this study (98.5% for IgG and 78.5% for IgM), the need of a confirmatory test for the diagnosis of Lyme disease remains. All the sera were also tested by two different commercial Western Blot (WB) assays: Euroline-WB against Borrelia, Euroimmun, and Qualicode B. burgdorferi WB, Immunetics, in comparison with a multispecies "home made" WB. Performances of the three WB methods for the detection of IgM were very similar. On the contrary, these WBs performed with different values of sensitivity and specificity when IgGs were evaluated. The most sensitive method was the "home-made" WB IgG (71.7%), followed by the Euroline-WB IgG against Borrelia (68.3%). Qualicode B. burgdorferi WB IgG demonstrated to be only 26.6% sensitive. Both "home-made" WB IgG and Qualicode B. burgdorferi WB IgG were 100% specific, whereas Euroline-WB IgG against Borrelia scored 12 cross-reacting samples as borderline, showing a specificity value of 80.0%.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15782625

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  12 in total

1.  A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis.

Authors:  Mario T Philipp; Gary P Wormser; Adriana R Marques; Susan Bittker; Dale S Martin; John Nowakowski; Leonard G Dally
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

2.  Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.

Authors:  Thomas B Ledue; Marilyn F Collins; John Young; Martin E Schriefer
Journal:  Clin Vaccine Immunol       Date:  2008-10-22

3.  Serologic evaluation of patients from Missouri with erythema migrans-like skin lesions with the C6 Lyme test.

Authors:  Mario T Philipp; Edwin Masters; Gary P Wormser; Wayne Hogrefe; Dale Martin
Journal:  Clin Vaccine Immunol       Date:  2006-10

4.  A decrease in the immunoglobulin G antibody response against the VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease.

Authors:  Antonella Marangoni; Vittorio Sambri; Silvia Accardo; Francesca Cavrini; Valeria Mondardini; Alessandra Moroni; Elisa Storni; Roberto Cevenini
Journal:  Clin Vaccine Immunol       Date:  2006-04

5.  Borrelia burgdorferi spirochetes that harbor only a portion of the lp28-1 plasmid elicit antibody responses detectable with the C6 test for Lyme disease.

Authors:  Monica E Embers; Gary P Wormser; Ira Schwartz; Dale S Martin; Mario T Philipp
Journal:  Clin Vaccine Immunol       Date:  2006-11-15

6.  Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.

Authors:  Dean A Jobe; Steven D Lovrich; Krista E Asp; Michelle A Mathiason; Stephanie E Albrecht; Ronald F Schell; Steven M Callister
Journal:  Clin Vaccine Immunol       Date:  2008-04-16

7.  Epitope length, genospecies dependency, and serum panel effect in the IR6 enzyme-linked immunosorbent assay for detection of antibodies to Borrelia burgdorferi.

Authors:  Maria J C Gomes-Solecki; Luciana Meirelles; John Glass; Raymond J Dattwyler
Journal:  Clin Vaccine Immunol       Date:  2007-05-30

8.  Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis.

Authors:  A Marangoni; A Moroni; S Accardo; R Cevenini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-16       Impact factor: 3.267

Review 9.  A 60-Year-Old Swiss Woman Presenting with Migratory Radicular Pain Diagnosed with Lyme Disease by Western Blot.

Authors:  Gisela Marcelino; João Cerveira; André Teychené; Armand Eichenberger
Journal:  Am J Case Rep       Date:  2022-04-10

Review 10.  The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis.

Authors:  M M G Leeflang; C W Ang; J Berkhout; H A Bijlmer; W Van Bortel; A H Brandenburg; N D Van Burgel; A P Van Dam; R B Dessau; V Fingerle; J W R Hovius; B Jaulhac; B Meijer; W Van Pelt; J F P Schellekens; R Spijker; F F Stelma; G Stanek; F Verduyn-Lunel; H Zeller; H Sprong
Journal:  BMC Infect Dis       Date:  2016-03-25       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.